Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00089154
Status:
COMPLETED
Last Update Posted:
2013-07-16
First Post:
2004-08-04
Brief Title:
Apolizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Small Lymphocytic Lymphoma |
| Noncontiguous Stage II Small Lymphocytic Lymphoma |
| Recurrent Small Lymphocytic Lymphoma |
| Refractory Chronic Lymphocytic Leukemia |
| Stage III Small Lymphocytic Lymphoma |
Keywords: